Research Interests
Research Interests
Dr. Green’s Biomaterials and Drug Delivery Laboratory is interested in biomaterials, drug delivery, gene therapy, nanobiotechnology, and cell engineering. Research findings — and the technologies developed — are applied in the fields of ophthalmology, oncology, and regenerative medicine.
The lab works within the chemistry/biology/engineering interface to answer fundamental scientific questions, and to create innovative technologies and therapeutics that can directly benefit human health.
Current projects include:
- Development of safe and effective biodegradable nanoparticles for DNA and siRNA delivery to treat cancer
- Polymeric microparticle-based biological treatments for age-related macular degeneration
- Design of biomimetic artificial antigen presenting cells for immunoengineering
- Enabling technologies for tissue engineering and regenerative medicine
Titles & Affiliations
Titles
- Herschel L. Seder Professor, Biomedical Engineering
- Vice Chair for Research and Translation, Department of Biomedical Engineering
- Professor, Ophthalmology
- Professor, Oncology
- Professor, Neurosurgery
- Professor, Materials Science & Engineering
- Professor, Chemical & Biomolecular Engineering
Affiliated Centers & Institutes
Education
Education
- PhD, Biological Engineering, Massachusetts Institute of Technology, 2007
- BS, Chemical Engineering, Biomedical Engineering, Carnegie Mellon University, 2003
Faculty News
Recent Highlights
-
March 7, 2025What if 30% of the medicines you and your loved ones depend on were never invented? Between 2001 and 2019,...
-
December 18, 2024Through tailored training and engagement opportunities, fellows will become skilled in providing expert media commentary, proficient at adapting their message to various audiences and stakeholders, able to identify emerging topics of broad interest, and equipped to craft compelling narratives.
-
October 4, 2024The 6.4 million, five-year award will support the ongoing development of tools and methods for the advancement of immunoengineering.
Media